As on Wednesday, Arvinas Inc (NASDAQ: ARVN) got off with the flyer as it spiked 3.83% to $7.87, before settling in for the price of $7.58 at the close. Taking a more long-term approach, ARVN posted a 52-week range of $5.90-$30.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -5.32%. Meanwhile, its Annual Earning per share during the time was -5.32%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 50.12%. This publicly-traded company’s shares outstanding now amounts to $73.00 million, simultaneously with a float of $63.64 million. The organization now has a market capitalization sitting at $574.44 million. At the time of writing, stock’s 50-day Moving Average stood at $7.32, while the 200-day Moving Average is $15.13.
Arvinas Inc (ARVN) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Arvinas Inc’s current insider ownership accounts for 12.81%, in contrast to 88.87% institutional ownership. According to the most recent insider trade that took place on Jun 24 ’25, this organization’s Chief Financial Officer sold 5,700 shares at the rate of 7.61, making the entire transaction reach 43,377 in total value, affecting insider ownership by 164,401.
Arvinas Inc (ARVN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.
Arvinas Inc’s EPS increase for this current 12-month fiscal period is 50.12% and is forecasted to reach -3.11 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -3.57% through the next 5 years, which can be compared against the -5.32% growth it accomplished over the previous five years trading on the market.
Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators
Let’s observe the current performance indicators for Arvinas Inc (ARVN). It’s Quick Ratio in the last reported quarter now stands at 4.58. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.57.
In the same vein, ARVN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.08, a figure that is expected to reach -0.94 in the next quarter, and analysts are predicting that it will be -3.11 at the market close of one year from today.
Technical Analysis of Arvinas Inc (ARVN)
Through scrutinizing the latest numbers posted by the [Arvinas Inc, ARVN], it can be observed that its last 5-days Average volume of 2.05 million was lower the volume of 2.19 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 38.93% While, its Average True Range was 55.99%.
Raw Stochastic average of Arvinas Inc (ARVN) in the period of the previous 100 days is set at 15.12%, which indicates a major fall in contrast to 55.56% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.42 that was lower than 0.58 volatility it exhibited in the past 100-days period.
